{
  "paper_metadata": {
    "pmid": null,
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on a BRCA2 variant associated with breast cancer and glioblastoma."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.1963del5",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "48-year-old female",
        "phenotype": "triple-negative breast cancer and glioblastoma"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 48,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "triple-negative invasive ductal carcinoma and glioblastoma",
          "evidence_sentence": "Herein, we report a woman who is a carrier of a familial BRCA2 mutation, and was previously diagnosed with triple-negative breast cancer (TNBC) and subsequently with a second primary TNBC and glioblastoma."
        }
      ],
      "functional_data": {
        "summary": "The specific functional impact of the c.1963del5 variant was not detailed in the paper.",
        "assays": []
      },
      "segregation_data": "The variant is part of a familial mutation.",
      "population_frequency": null,
      "evidence_level": "case report",
      "source_location": "Case Report, paragraph 4",
      "additional_notes": "The patient had a strong family history of breast cancer.",
      "key_quotes": [
        "The patient is a 48-year-old woman with a family history of breast cancer, who had presented with a lump in her left breast 10 years previously.",
        "However, when she was examined at our cancer center, genetic screening for BRCA1 and BRCA2 mutations was performed, and a mutation (1963del5) was identified in the BRCA2 gene."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "The extraction was straightforward as the paper provided clear information on the BRCA2 variant."
  }
}